Prescribing Information | RYPLAZIM (plasminogen, human-tvmh)

Full Prescribing Information For Healthcare Professionals

About RYPLAZIM

What is RYPLAZIM? RYPLAZIM results Safety Using RYPLAZIM

About PLGD-1

About PLGD-1? PLGD-1 symptoms & signs About ligneous conjunctivitis Lesion appearance Diagnosing PLGD-1

Resources

Cost & support Downloadable resources Community Real patient stories Lesion image gallery

FAQs

Connect with a nurse educator

PRESCRIBING INFORMATION

Loading prescribing information...

PDF preview is unavailable. Open the PDF in a new tab.

©2026 Kedrion Biopharma Inc. All rights reserved. RYPLAZIM and the
RYPLAZIM logo are registered trademarks of Kedrion Biopharma Inc.
All other trademarks are the property of their respective owners.
February 2026 RY-0270-00-2026

Privacy Notice | Terms of Use | Accessibility Statement | Site Map

This website is intended for US residents only.

CANCEL

You are now leaving www.RYPLAZIM.com

Select OK to continue to the external website or Cancel to stay on this page.

OK

Search

About RYPLAZIM About PLGD-1 Resources FAQs

Connect with a nurse educator

About RYPLAZIM

What is RYPLAZIM? RYPLAZIM results Safety Using RYPLAZIM

About PLGD-1

About PLGD-1 About ligneous conjunctivitis PLGD-1 symptoms & signs Lesion appearance Diagnosing PLGD-1

Resources

Cost & support Downloadable resources Community Real patient stories Lesion image gallery

FAQs